FHN Nocturnal Trial results published in Kidney International Print
FHN Investigators: Conclusion: Patients in the nocturnal arm had improved control of hyperphosphatemia and hypertension, but no significant benefit among the other main secondary outcomes. There was a trend for increased vascular access events in the nocturnal arm. Thus, we were unable to demonstrate a definitive benefit of more frequent nocturnal hemodialysis for either coprimary outcome. Kidney International (2011) 80, 1080–1091

...